1. Home
  2. LZ vs APLT Comparison

LZ vs APLT Comparison

Compare LZ & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LZ
  • APLT
  • Stock Information
  • Founded
  • LZ 2001
  • APLT 2016
  • Country
  • LZ United States
  • APLT United States
  • Employees
  • LZ N/A
  • APLT N/A
  • Industry
  • LZ EDP Services
  • APLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • LZ Technology
  • APLT Health Care
  • Exchange
  • LZ Nasdaq
  • APLT Nasdaq
  • Market Cap
  • LZ 1.4B
  • APLT 971.6M
  • IPO Year
  • LZ 2021
  • APLT 2019
  • Fundamental
  • Price
  • LZ $8.49
  • APLT $10.09
  • Analyst Decision
  • LZ Hold
  • APLT Strong Buy
  • Analyst Count
  • LZ 8
  • APLT 5
  • Target Price
  • LZ $7.88
  • APLT $12.50
  • AVG Volume (30 Days)
  • LZ 1.1M
  • APLT 1.7M
  • Earning Date
  • LZ 11-06-2024
  • APLT 11-07-2024
  • Dividend Yield
  • LZ N/A
  • APLT N/A
  • EPS Growth
  • LZ 212.91
  • APLT N/A
  • EPS
  • LZ 0.13
  • APLT N/A
  • Revenue
  • LZ $678,838,000.00
  • APLT N/A
  • Revenue This Year
  • LZ $6.08
  • APLT N/A
  • Revenue Next Year
  • LZ $3.66
  • APLT $3,169.03
  • P/E Ratio
  • LZ $65.03
  • APLT N/A
  • Revenue Growth
  • LZ 4.65
  • APLT N/A
  • 52 Week Low
  • LZ $5.33
  • APLT $1.79
  • 52 Week High
  • LZ $13.74
  • APLT $10.09
  • Technical
  • Relative Strength Index (RSI)
  • LZ 69.06
  • APLT 71.91
  • Support Level
  • LZ $7.06
  • APLT $9.44
  • Resistance Level
  • LZ $9.31
  • APLT $9.98
  • Average True Range (ATR)
  • LZ 0.28
  • APLT 0.58
  • MACD
  • LZ 0.18
  • APLT 0.05
  • Stochastic Oscillator
  • LZ 67.72
  • APLT 100.00

About LZ LegalZoom.com Inc.

LegalZoom.com Inc is an online provider of services that meet the legal needs of small businesses and consumers in the United States. The company also offers services that include ongoing compliance and tax advice and filings, business licenses, accounting, virtual mailbox and e-signature solutions, trademark filings, and estate plans.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: